HER2 upregulation was reported to induce a remarkable increase in the rate of cell proliferation alongside apoptosis inhibition, contributing to the pathogenesis as well as the development of an array of malignancies, chiefly breast cancer (Hsu and Hung, 2016). Here, ERBB2 is linked to breast carcinoma.